Cargando…
The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
BACKGROUND: A myositis-specific autoantibody can now be identified in the majority of patients with myositis. They identify homogeneous patient subgroups and are key tools in developing a personalized approach to disease management. There is substantial clinical interest in exploiting myositis autoa...
Autores principales: | Tansley, Sarah L., Snowball, Julia, Pauling, John D., Lissina, Anya, Kuwana, Masataka, Rider, Lisa G., Rönnelid, Johan, McHugh, Neil J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227250/ https://www.ncbi.nlm.nih.gov/pubmed/32414409 http://dx.doi.org/10.1186/s13075-020-02210-2 |
Ejemplares similares
-
The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020) -
The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
por: Loganathan, Aravinthan, et al.
Publicado: (2022) -
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
por: Betteridge, Zoe E, et al.
Publicado: (2011) -
Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies
por: Mahler, Michael, et al.
Publicado: (2019) -
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)